Biomarkers in Cardiorenal Syndrome

Cardiorenal syndrome is a clinical manifestation of the bidirectional interaction between the heart and kidney diseases. Over the last years, in patients with cardiovascular diseases, several biomarkers have been studied in order to better assess renal function as well as to identify patients prone to experiencing chronic or acute worsening of renal function. The aim of this review is to focus on the possible clinical usefulness of the most recent biomarkers in the setting of cardiorenal syndrome.

Automated summary

Cardiorenal syndrome is a clinical manifestation of the bidirectional interaction between heart and kidney diseases. Multiple biomarkers have been studied over recent years to better assess renal function and identify patients at risk of chronic or acute worsening of kidney function. This review aims to discuss the potential clinical utility of the latest biomarkers in the context of cardiorenal syndrome.